Drug Shortage Report for AURO-EMTRICITABINE-TENOFOVIR
| Report ID | 223603 |
| Drug Identification Number | 02490684 |
| Brand name | AURO-EMTRICITABINE-TENOFOVIR |
| Common or Proper name | AURO-EMTRICITABINE-TENOFOVIR |
| Company Name | AURO PHARMA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | EMTRICITABINE TENOFOVIR DISOPROXIL FUMARATE |
| Strength(s) | 200MG 300MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 's |
| ATC code | J05AR |
| ATC description | DIRECT ACTING ANTIVIRALS |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | |
| Actual start date | 2024-03-27 |
| Estimated end date | 2024-04-30 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2024-03-28 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 3700 STEELES AVENUE WEST, SUITE 402 WOODBRIDGE, ONTARIO CANADA L4L 8K8 |
| Company contact information | Balaji Srinivasan |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v3 | 2024-03-28 | English | Compare |
| v2 | 2024-03-27 | French | Compare |
| v1 | 2024-03-27 | English | Compare |
Showing 1 to 3 of 3